Technology

Medicine is entering a new era of “gene editing.” Instead of simply being able to “read” our genes, practitioners will be able to adapt and modify DNA sequencing in living cells to treat, cure, and even prevent disease. Defective genes responsible for life-threatening diseases can be rendered harmless by gene editing; it can also be used to develop new, precisely targeted biological drugs based on an individual’s distinct genetic markers. The full list of possibilities, in every area of the life sciences, is simply beyond imagination.

October 16, 2015.

October 16, 2015.

October 14, 2015.

October 12, 2015.

October 09, 2015.

October 09, 2015.

October 08, 2015.

October 08, 2015.

October 08, 2015.

October 08, 2015.

October 07, 2015.

October 07, 2015.

October 07, 2015.

The rising focus on difficulties in swallowing tablets spells a big opportunity for pharma.

October 02, 2015.

October 06, 2015.

October 06, 2015.

October 5, 2015.

October 05, 2015.

October 05, 2015.

October 02, 2015.

October 01, 2015.

Life sciences companies must go beyond digitizing individual operations, and instead harness digital to design and construct entirely new business models, writes Brags Srinivasan.

October 01, 2015.

October 01, 2015.

October 02, 2015.

The UK's National Health Services needs to rethink the ‘sticking plaster’ solution of training replacement staff, writes James Brook.

September 30, 2015.

September 30, 2015.